Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Comera Life Sciences第二季度每股收益为0.08美元，高于同比（1.14美元），销售额为315.06万美元，高于同比的14.673万美元
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.08) per share. This is a 92.98 percent increase over losses of $(1.14) per share from the same period last year. The company reported $315.06 thousand in sales this quarter. This is a 114.72 percent increase over sales of $146.73 thousand the same period last year.
Comera Life Sciences（纳斯达克股票代码：CMRA）公布季度每股亏损0.08美元。这比去年同期的每股亏损（1.14美元）增加了92.98％。该公司报告本季度销售额为315.06万美元。这比去年同期的14.673万美元的销售额增长了114.72％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。